Wellington, NZ, 20th December 2016: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, is pleased to announce that its recent entitlement offer closed as scheduled on 15 December 2016, raising a total of A$3.7 million (approximately NZ$3.9 million).
Approximately A$2.3 million (NZ$2.5 million) being 62% of the total entitlements available for subscription were taken up by existing shareholders under the entitlement offer and all applications for additional shares were satisfied in full leaving a shortfall of approximately A$1.4 million (NZ$1.5 million). The underwriter, Morgans Corporate Limited has placed the shortfall with investors.
As previously announced the total proceeds of the entitlement offer, together with the proceeds of the placement announced on 22 November 2016, is approximately A$10.7 million (NZ$11.2 million). The funds will be used for working capital and to continue expansion of US sales force.
For further information please download PDF attached:
Download this document
